Diagnostic Specialty Enzyme Market Size, Share, Growth Report 2030

Diagnostic Specialty Enzyme Market

Diagnostic Specialty Enzyme Market - by Product (Protease, Polymerases, Lipase, and Carbohydrases), and Application (Immunoassays, Clinical Chemistry, and Molecular Diagnostics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3628 Published Date: Sep-2020 Status : Published

global diagnostic specialty enzyme market size was valued at approximately USD 780 Million in 2019 and is to generate revenue of around USD 1,240 Million by end of 2026, growing CAGR of around 8% between 2020 and 2026.

Diagnostic Specialty Enzyme Market

According to the report published by Zion Market Research, global diagnostic specialty enzyme market size was valued at approximately USD 780 Million in 2019, and is expected to generate revenue of around USD 1,240 Million by end of 2026, growing at a CAGR of around 8% between 2020 and 2026.

Global Diagnostic Specialty Enzyme Market SizeRequest Free Sample

Global Diagnostic Specialty Enzyme Market: Overview

Diagnostic specialty enzymes find applications in low volume and high value-added applications. Major use of diagnostic specialty enzymes is in clinical chemistry, molecular diagnostics, and immunoassay. They help in reduction of systemic inflammation, enhancing muscle mass, making immune system stronger, and assist in breaking down as well as digesting food.

Global Diagnostic Specialty Enzyme Market: Growth Factors

Increase in biotech & diagnostic applications and rise in occurrence of chronic, infectious, and lifestyle diseases are anticipated to propel the growth of the global market from 2018 to 2026. The global diagnostic specialty enzymes market is driven by surge in investments, early as well as instantaneous diagnosis of life-threatening ailments, and rise in geriatric population in the developed countries. However, lack of customer education and adoption, and technical complex and niche nature are the major restraints of the global diagnostic specialty enzymes market. Nevertheless, the increase in the rate of the patients affected as a result of contagious ailments and other lifestyle related disorders will enhance the demand for diagnostic specialty enzymes market in the years to come.

Heavy funding of activities pertaining to biotechnology and genetics by pharmaceutical firms and rise in diagnostics testing with diminishing DNA sequencing costs resulting in massive testing of food, medical, and agricultural products will further propel diagnostic specialty enzymes market growth in the years ahead. In addition, huge investments made by leading Pharma firms to boost R&D activities related to biologics will further scale up the growth of diagnostic specialty enzymes market in the estimated timeline.

Global Diagnostic Specialty Enzyme Market: Segmentation

The global diagnostic specialty enzymes market can be divided based on product and application. Product wise, the diagnostic specialty enzymes market is segmented into Protease, polymerases, lipase, and carbohydrases. Based on the application, the market is sectored into immunoassays, clinical chemistry, and molecular diagnostics.

Global Diagnostic Specialty Enzyme Market: Regional Analysis

Based on regions, the global diagnostic specialty enzymes market can be divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America captured the largest share of the global diagnostic specialty enzymes market in 2017. Increase in acceptance of new biotechnology technologies such as next generation sequencing along with massive awareness and significant research spending in overall national budgets boosts the growth of the market in the U.S.

Asia Pacific is projected to acquire large market share during the forecast timeline and is likely to be the key region in terms of revenue in the next few years. Development of health care infrastructure, rise in population, growth of the biotechnology industry, and increase in burden of diseases necessitating diagnostics in Brazil, South Africa, Saudi Arabia, etc. are likely to propel the growth of the diagnostic specialty enzymes market in Latin America and Middle East & Africa.

Global Diagnostic Specialty Enzyme Market: Competitive Players

Some main participants of the diagnostic specialty enzyme market are

  • Robert F. Hoffmann-La Roche Ltd.
  • Novozymes A/S
  • Codexis, Inc.
  • Micogen, Inc.
  • Amano Enzymes, Inc.
  • Affymetrix, Inc. 
  • Thermo Fisher Scientific, Inc.
  • American Laboratories, Inc.
  • Amano Enzymes Inc.
  • Biocatalysts Ltd.
  • Advanced Enzymes Technologies Ltd.
  • BBI Solutions

The global Diagnostic Specialty Enzyme Market is segmented as follows:

By Product 

  • Protease
  • Polymerases
  • Lipase
  • Carbohydrases 

By Application 

  • Immunoassays
  • Clinical Chemistry
  • Molecular Diagnostics

Diagnostic Specialty Enzyme Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

One of the primary growth driving factor of the diagnostic specialty enzyme market is increasing prevalence of chronic and infectious diseases in urban parts. Further, investment in biotechnology and genetics by pharmaceutical firms has also played a vital role in fuelling the market growth.

According to the report published by Zion Market Research, global diagnostic specialty enzyme market was valued at approximately USD 780 Billion in 2019, and is expected to generate revenue of around USD 1,240 Million by end of 2026, growing at a CAGR of around 8% between 2020 and 2026.

The Asia Pacific diagnostic specialty enzyme market is projected to hold the largest share globally in the future. Soaring health care infrastructure and growing population has led to increasing consumption of diagnostic specialty enzyme, which has driven the Asia Pacific diagnostic specialty enzyme market.

Some main participants of the diagnostic specialty enzyme market are Robert F. Hoffmann-La Roche Ltd., Novozymes A/S, Codexis, Inc., Micogen, Inc., Amano Enzymes, Inc., Affymetrix, Inc. Thermo Fisher Scientific, Inc., American Laboratories, Inc. Amano Enzymes Inc., Biocatalysts Ltd., Advanced Enzymes Technologies Ltd., and BBI Solutions,

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed